WSB1 as a Maker for Metastasis and Therapeutic Target for the HIF Pathway

Technology #2015-164

Questions about this technology? Ask a Technology Manager

Download Printable PDF

Categories
Researchers
Zhenkun Lou Ph.D.
SeungBaek Lee Ph.D.
JungJin Kim Ph.D.
Managed By
Tim D. Argo
Patent Protection
US Patent Pending
US Patent Pending

Mayo Clinic has discovered that WSB1 can be used as a diagnostic marker for tumor metastasis and a therapeutic target.